Botanical species · safety record

Lactuca virosa

The EFSA Compendium of Botanicals holds 12 constituent measurements and 1 adverse-effect record for Lactuca virosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lactuca virosa L.

12Constituent measurements
1Safety records
4Cited sources
51Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 51 licensed products naming Lactuca virosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Fresh

Source material stated

  • Fresh above ground parts
  • Herb
  • Leaf
  • Leaf/Leaves
  • Leaves
  • Plante entière
  • Sève
  • Whole plant

What the records describe

Constituents measured

  • Sesquiterpene lactones10
  • Lactucin1
  • Lactucopicrin1

Plant parts

  • Leaves5
  • Roots and other underground parts4
  • Live plants3
  • Aerial part of plants1

Preparations

  • Solvent extraction12
  • Raw, no heat treatment1

Effect types

  • Systemic1

Target tissues

  • Neurologic: central nervous system1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LactucinLive plantsSolvent extraction256.9 Microgram/gramHPLC-UVResolve DOI
LactucopicrinLive plantsSolvent extraction1732.7 Microgram/gramHPLC-UVResolve DOI
Sesquiterpene lactonesLeavesSolvent extraction≤ 0.25 Milligram/gramHPLC-DADResolve DOI
Sesquiterpene lactonesLeavesSolvent extraction≥ 0.025 Milligram/gramHPLC-DADResolve DOI
Sesquiterpene lactonesRoots and other underground partsSolvent extraction≥ 0.025 Milligram/gramHPLC-DADResolve DOI
Sesquiterpene lactonesRoots and other underground partsSolvent extraction≤ 0.25 Milligram/gramHPLC-DADResolve DOI
Sesquiterpene lactonesLive plantsSolvent extraction173.5 Microgram/gramHPLC-UVResolve DOI
Sesquiterpene lactonesLeavesSolvent extraction< 0.025 Milligram/gramHPLC-DADResolve DOI
Sesquiterpene lactonesRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Sesquiterpene lactonesRoots and other underground partsSolvent extraction< 0.025 Milligram/gramHPLC-DADResolve DOI
Sesquiterpene lactonesLeavesSolvent extraction≤ 2.5 Milligram/gramHPLC-DADResolve DOI
Sesquiterpene lactonesLeavesSolvent extraction≥ 0.25 Milligram/gramHPLC-DADResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
SystemicNeurologic: central nervous systemAerial part of plantsRaw, no heat treatmentHuman (as organism)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Michalska, Klaudia., Stojakowska, Anna., Malarz, Janusz., Dolezalova, Ivana., Lebeda, Ales., Kisiel, Wanda. Systematic implications of sesquiterpene lactones in Lactuca species. BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2009, vol. 37, no. 3, p. 174-179. DOI
  2. TAMAKI, H., ROBINSON, RW., ANDERSON, JL., STOEWSAND, GS. SESQUITERPENE LACTONES IN VIRUS-RESISTANT LETTUCE. Journal of agricultural and food chemistry, 1995, vol. 43, no. 1, p. 6-8. DOI
  3. Kisiel, W., Barszcz, B. Minor sesquiterpene lactones from Lactuca virosa. Phytochemistry, 1997, vol. 46, no. 7, p. 1241-1243. DOI
  4. Besharat, Sima., Besharat, Mahsa., Jabbari, Ali. Wild lettuce (Lactuca virosa) toxicity.. Bmj case reports, 2009, vol. 2009. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue